AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary

AngioDynamics

14/07/2026 14:31

AngioDynamics Inc ANGO.OQ reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended May 31, lower than the same quarter last year, when the company reported EPS of -3 cents.  The mean expectation of three analysts for the quarter was for a loss of 9 cents per share. Wall Street expected results to range from -11 cents to -7 cents per share.
Revenue rose 8% to $86.61 million from a year ago; analysts expected $80.40 million. 
AngioDynamics Inc's reported EPS for the quarter was a loss of 27 cents​.
The company reported a quarterly loss of $11.41 million.
AngioDynamics Inc shares had fallen by 1.8% this quarter and lost 0.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for AngioDynamics Inc is $16.00, about 20.2% above its last closing price of $12.78
This summary was machine generated from LSEG data July 14 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
May. 31 2026 
-0.09
-0.07
Beat
Feb. 28 2026 
-0.11
0.02
Beat
Nov. 30 2025 
-0.10
0.00
Beat
Aug. 31 2025 
-0.12
-0.10
Beat